Improving treatment of pancreatic cancer

Lancet Oncol. 2008 Jan;9(1):7-8. doi: 10.1016/S1470-2045(07)70391-1.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cetuximab
  • Cisplatin / administration & dosage
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • ErbB Receptors / antagonists & inhibitors*
  • Erlotinib Hydrochloride
  • Gemcitabine
  • Humans
  • Pancreatic Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / pharmacology*
  • Quinazolines / pharmacology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Protein Kinase Inhibitors
  • Quinazolines
  • Deoxycytidine
  • Erlotinib Hydrochloride
  • ErbB Receptors
  • Cetuximab
  • Cisplatin
  • Gemcitabine